INSIGHTS ON CLINICAL TRIAL DESIGN
-
![Speed Kills]( "Speed Kills: When Timelines Trump Science In Neuropsychiatric Trials")
Speed Kills: When Timelines Trump Science In Neuropsychiatric TrialsThis Bold Conversation brings together experts helping to define the next chapter of psychedelic clinical research to unpack lessons from recent regulatory reviews and explore what clinical teams need now.
-
![375_250-clinical_trial_payment_gettyimages_2279596023]( "Can Your Trial Payment Approach Stand Up To Regulatory Scrutiny?")
Can Your Trial Payment Approach Stand Up To Regulatory Scrutiny?Fragmented trial payment systems create compliance, ethical, and operational risks. Aligning payments with regulations and ethics improves transparency, reduces burden, and supports audits and participation.
-
![GettyImages-1278800031 diverse trial participants]( "The Evolving Role Of Healthy Participants In Early Immuno-Oncology Trials")
The Evolving Role Of Healthy Participants In Early Immuno-Oncology TrialsExplore how leveraging healthy participants, advanced immune-challenge models, and high-dimensional biomarker analyses can transform early immuno-oncology development.
-
![clinical-trial-design-GettyImages-2246070389]( "Why Early Clinical Development Is Shifting Toward Decision-Enabling Study Designs")
Why Early Clinical Development Is Shifting Toward Decision-Enabling Study DesignsEarly clinical research is shifting to decision-focused designs, using biomarkers, functional endpoints, and targeted populations to reduce uncertainty and enable clearer progression.
-
Taking A Statistics-Driven Approach To Clinical Trial Planning3/12/2025
Clinical trials are inherently complex, and even well-structured studies may struggle to achieve statistical significance due to challenges in study design, patient selection, and data variability.
-
Operationalizing Immuno-Oncology Studies5/29/2026
Managing CRS and immune risks demands early detection, rapid response, and skilled teams. Strong infrastructure and clear protocols enable safer immunotherapy trials beyond academic centers.
-
The True ROI Of Decentralized Clinical Trials11/13/2025
Gain a greater understanding of how the right DCT solution, or combination of solutions, coupled with clear metrics and expert guidance on execution, can demonstrate tangible, quantitative ROI in clinical trials.
-
Obesity Clinical Research: Patient Recruitment Challenges1/15/2026
Obesity trials face enrollment hurdles. Learn how data-driven insights, patient-first strategies, and decentralized models can break barriers, ease burden, and accelerate timelines.
-
Streamlining The Clinical Trial Workflow From Protocol Design To Regulatory Submission1/27/2026
Learn how to create a direct line from clinical planning and protocol design to clinical trial disclosure to optimize efficiency across the entire trial lifecycle.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![clinical-trials-cros-GettyImages-1346675527]( "Deliver Supply Without Friction. Maintain Control At Every Step")
Learn how clinical supply organizations can reduce manual effort, strengthen compliance, improve global coordination, and maintain control across evolving clinical trial supply chains.
-
![GettyImages-639668490 patient]( "Scout: Beyond The Numbers")
Patient retention has benefits beyond what’s reflected in a data set. Explore some of the ways clinical trial participation can have a transformative impact on patients and their families.
-
![Medical data iStock-1210343139]( "Accelerate Clinical Trial Cycle Times With Citeline Study Feasibility")
Citeline Study Feasibility is a platform that combines subject-matter expertise and machine learning to develop predictive insights for feasibility planning. Clinical trial sponsors can use these insights to identify key data drivers and model their impact, build and simulate feasibility scenarios, accelerate timelines, and make better decisions than with statistical methods alone.
-
![GettyImages-1388184871-quality-compliance-approval]( "Reviewing Protocols Across Therapeutic Areas")
A successful clinical trial starts with an efficient protocol review.
With deep roots in academic research and clinical medicine, BRANY IRB is uniquely positioned to meet your cost and speed requirements. Get your clinical trial to the start line while ensuring participant health and safety.
-
![Rare Disease Clinical Trials – The Importance Of Rigorous Study Designs]( "Get Novel Infectious Disease Vaccines, Therapies To Market Faster")
Infectious diseases are a threat to global health and way of life everywhere. Time is of the essence when it comes to developing safe and effective infectious disease vaccines and treatments.
